Michal Abrahamowicz, PhD
biostatistics
cohort studies
comparative effectiveness
confounding
instrumental variables
CHAL | Cardiovascular Health across the Lifespan Program
Our Researchers
The Cardiovascular Health Across the Lifespan (CHAL) Program brings together seven basic researchers, thirty clinician-scientists and eight health outcomes researchers. Researchers from the Centre for Translational Biology (CTB) conduct basic research projects related to vascular function and related diseases, especially atherosclerosis, hypercholesterolemia and vascular injury. Investigators from the Centre for Innovative Medicine (CIM) focus their research on surgery outcomes and on improving prevention and care in patients affected by such cardiac diseases as heart failure, arrhythmias and valve diseases. Investigators from the Centre for Outcomes Research and Evaluation (CORE) seek to develop networks, databases and new tools to improve population health. These include epidemiological outcome and intervention studies on congenital heart disease (CHD), and different factors (genetic, environmental, gender-based) for cardiovascular diseases. CHAL researchers are based at the Glen site, at the heritage site of the Royal Victoria Hospital of the MUHC and at 5252 de Maisonneuve Boulevard W.
Filters
Displaying 13 result(s).
|
CORE |
|
James Brophy, MD, PhDcardiovascular epidemiology pharmacoepideiology Bayesian statistics CORE |
|
Natalie Dayan, MD, M.Sc., FRCPCepidemiology clinical research women's health pregnancy maternal health CORE |
|
Mark Goldberg, B.Sc., M.Sc., PhDepidemiology environment occupation cancer cardiorespiratory diseases CORE |
|
Isabelle Malhamé, MD, M.Sc., FRCPCpregnancy • postpartum • severe maternal morbidity • maternal mortality • preeclampsia • peripartum cardiomyopathy • venous thromboembolism CORE |
|
Ariane Marelli, MD, MPH, FRCPC, FACC, FAHAhealth services epidemiology congenital heart disease cardiovascular cardiology CORE |
|
Louise Pilote, MD, MPH, PhD, FRCPCcomparative effectivenesse sex differences in cardiovascular diseases outcomes research cardiovascular epidemiology pharmacoepidemiology CORE |
|
Marc Rodger, MD, M.Sc.Venous thrombosis • pulmonary embolism • pregnancy • anticoagulation • diagnosis • clinical decision rules • networks CORE |
|
Allan Sniderman, MDprevention cardiovascular disease atherosclerosis apoB CORE |
|
Robyn Tamblyn, MScN, M.Sc., PhD, CMhealth services medical education medical informatics practice changes pharmacoepidemiology CORE |
|
George Thanassoulis, MDGenetics genomics cardiovascular disease aortic stenosis myocardial infarction CORE |